• 92 Citations
20072020
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2013Residency, Columbia University, New York Presbyterian Hospital
2016Fellowship, National Institutes of Health (NIH)

Education/Academic qualification

MD, PhD, Albert Einstein College of Medicine

… → 2010

Fingerprint Dive into the research topics where Fei Li Kuang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Hypereosinophilic Syndrome Medicine & Life Sciences
Eosinophilia Medicine & Life Sciences
Eosinophils Medicine & Life Sciences
Histone Code Medicine & Life Sciences
Biological Factors Medicine & Life Sciences
Genetic Recombination Medicine & Life Sciences
Chromatin Medicine & Life Sciences
Cytosine Deaminase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2020

  • 92 Citations
  • 4 Article
  • 1 Conference contribution
  • 1 Review article

Approach to Patients with Eosinophilia

Kuang, F. L., Jan 2020, In : Medical Clinics of North America. 104, 1, p. 1-14 14 p.

Research output: Contribution to journalReview article

Eosinophilia
Eosinophils
Blood Cell Count
Biomarkers
Pathology
14 Citations (Scopus)

Benralizumab for PDGFRA-negative hypereosinophilic syndrome

Kuang, F. L., Legrand, F., Makiya, M., Ware, J. A., Wetzler, L., Brown, T., Magee, T., Piligian, B., Yoon, P., Ellis, J. H., Sun, X., Panch, S. R., Powers, A., Alao, H., Kumar, S., Quezado, M., Yan, L., Lee, N., Kolbeck, R., Newbold, P. & 5 others, Goldman, M., Fay, M. P., Khoury, P., Maric, I. & Klion, A. D., Apr 4 2019, In : New England Journal of Medicine. 380, 14, p. 1336-1346 11 p.

Research output: Contribution to journalArticle

Open Access
Hypereosinophilic Syndrome
Eosinophils
Placebos
Eosinophilia
benralizumab
19 Citations (Scopus)

Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome

Kuang, F. L., Fay, M. P., Ware, J. A., Wetzler, L., Holland-Thomas, N., Brown, T., Ortega, H., Steinfeld, J., Khoury, P. & Klion, A. D., Sep 1 2018, In : Journal of Allergy and Clinical Immunology: In Practice. 6, 5, p. 1518-1527.e5

Research output: Contribution to journalArticle

Hypereosinophilic Syndrome
Glucocorticoids
Therapeutics
mepolizumab
Interleukin-5
12 Citations (Scopus)

Biologic Agents for the Treatment of Hypereosinophilic Syndromes

Kuang, F. L. & Klion, A. D., Nov 2017, In : Journal of Allergy and Clinical Immunology: In Practice. 5, 6, p. 1502-1509 8 p.

Research output: Contribution to journalArticle

Hypereosinophilic Syndrome
Biological Factors
Eosinophils
Eosinophilia
Therapeutics
43 Citations (Scopus)
Open Access
Histone Code
Genetic Recombination
Chromatin
Cytosine Deaminase
Immunoglobulin Heavy Chains